Ilaria Ruffilli
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 16
- Thyroid Disorders and Treatments 15
- Oncology 20
- Cancer-related Molecular Pathways 7
- Chemokine receptors and signaling 6
- Co-authors
- Poupak FallahiAlessandro AntonelliSilvia Martina FerrariGiusy EliaFrancesca RagusaSabrina Rosaria PaparoArmando PatrizioSalvatore Benvenga
In The Last Decade
Ilaria Ruffilli
53 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 109
- Endocrinology, Diabetes and Metabolism 1.1k
- Oncology 528
- Immunology 405
- Pathology and Forensic Medicine 311
- Rheumatology 228
Countries citing papers authored by Ilaria Ruffilli
This map shows the geographic impact of Ilaria Ruffilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilaria Ruffilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilaria Ruffilli more than expected).
Fields of papers citing papers by Ilaria Ruffilli
This network shows the impact of papers produced by Ilaria Ruffilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilaria Ruffilli. The network helps show where Ilaria Ruffilli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ilaria Ruffilli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 84 | |
| 2 | 2020 | 102 | |
| 3 | 2019 | 34 | |
| 4 | 2019 | 17 | |
| 5 | 2018 | 47 | |
| 6 | 2018 | 15 | |
| 7 | 2017 | 23 | |
| 8 | 2017 | 29 | |
| 9 | 2017 | 22 | |
| 10 | 2017 | 27 | |
| 11 | 2016 | 13 | |
| 12 | 2016 | 146 | |
| 13 | 2015 | 48 | |
| 14 | 2015 | 17 | |
| 15 | 2014 | 9 | |
| 16 | CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo | 2012 | 11 |
| 17 | 2012 | 17 | |
| 18 | 2012 | 11 | |
| 19 | 2011 | 8 | |
| 20 | 2011 | 48 |
About Ilaria Ruffilli
Ilaria Ruffilli is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Gastroenterology, Rheumatology and Hepatology, having authored 54 papers that have together received 2.2k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (16 papers), Thyroid Disorders and Treatments (15 papers), Cancer-related Molecular Pathways (7 papers), Diabetes and associated disorders (6 papers), Systemic Lupus Erythematosus Research (6 papers), Chemokine receptors and signaling (6 papers), Urticaria and Related Conditions (5 papers) and Hepatitis C virus research (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Oncology (528 citations), Immunology (405 citations), Pathology and Forensic Medicine (311 citations) and Rheumatology (228 citations). Ilaria Ruffilli has collaborated with scholars based in Italy, Israel and Russia. Frequent co-authors include Poupak Fallahi, Alessandro Antonelli, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Salvatore Benvenga, Roberto Vita and Michele Colaci. Their work appears in journals such as Best Practice & Research Clinical Endocrinology & Metabolism, Autoimmunity Reviews, Immunologic Research, Frontiers in Endocrinology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.